Table of contents

Original research

• Clinical practice and teaching of pharmaceutical care procedures for obstetric diseases (31 May, 2020)

  Xianli Wang, Yanyu Pang, Mengmeng Wang, Jin Jing, Jing Tang
• Cost-minimisation analysis of rectal cancer neoadjuvant chemoradiotherapy based on fluoropyrimidines (capecitabine versus 5-fluorouracil) (27 March, 2020)

  Sergio Marin, Laia Pérez-Cordón, Francesc Salvà, Marcel·la Camps, Lluís Campins, Pilar Lianes
• The impact of paediatric dose range checking software (31 March, 2020)

  Matthew Neame, James Moss, Jordi Saez Dominguez, Andrea Gill, Nik Barnes, Ian Sinha, Daniel Hawcutt
• Off-label use of inhaled bronchodilators in hospitalised patients in Spain: a multicentre observational study (24 April, 2020)

  Elena Villamañán, Carmen Sobrino, Cristina Bilbao, Jaime Fernández, Alicia Herrero, Myriam Calle, Dolores Alvaro, Maria Segura, Gracia Picazo, José Miguel Rodríguez, Gema Baldominos, Maria Teresa Ramirez, Yolanda Larrubia, Jesús Llorente, Alicia Martinez, Rodolfo Alvarez-Sala
• Factors associated with a reduction in the quality of life of patients with chronic hepatitis C treated by ledipasvir/sofosbuvir therapy (3 April, 2020)

  Yuka Aimono, Noriko Kohyama, Toshiro Kamoshida, Toshinori Yamamoto, Mari Kogo
• Exploring the adverse effects of chemotherapeutic agents used in the treatment of cervical and ovarian cancer from the patients’ perspective: a content analysis of the online discussion forums (29 April, 2020)

  Sulaf Assi, Megan Barling, Abdullah Al-Hamid, Ejaz Cheema
• Utility of a trigger tool (TRIGGER-CHRON) to detect adverse events associated with high-alert medications in patients with multimorbidity (8 May, 2020)

  Maria Jose Otero, María Dolores Toscano Guzmán, Mercedes Galván-Banqueri, Jesus Martinez-Sotelo, María Dolores Santos-Rubio
• Medication persistence on biological therapies prescribed for the treatment of chronic inflammatory arthropathies: a real-world data study (13 May, 2020)

  Marisol Samartín-Ucha, Jose Maria Pego-Reigosa, Miriam Álvarez-Payero, Alicia Martin-Vila, Guadalupe Pineiro-Corrales, Maria Rodriguez-Rodriguez, Rafael Benito Melero-Gonzalez, Francisco Maceiras-Pan, Cristina Martinez-Reglero, Noemi Mrtinez-Lopez de Castro
• The potential risk factors of nephrotoxicity during vancomycin therapy in Chinese adult patients (10 June, 2020)

  Yulin Wang, Jian Yang, Haiyan Zhan, Shuxiao Zhang, Yin Deng
• Severe and fatal medication errors in hospitals: findings from the Norwegian Incident Reporting System (23 June, 2020)

  Alma Mulac, Katja Taxis, Ellen Hagesaether, Anne Gerd Granas
• Evaluation of quality indicators for nutrition and metabolism in critically ill patients: role of the pharmacist (23 June, 2020)

  Pelayo Nieto-Gómez, Rocío Morón Romero, Elena Planells del Pozo, Jose Cabeza-Barrera, Manuel Colmenero Ruiz
• Safety and effectiveness of a four-factor prothrombin complex concentrate for vitamin K antagonist reversal following a fixed-dose strategy (26 June, 2020)

  Carmen Sobrino Jiménez, José Antonio Romero-Garrido, Ángeles García-Martín, Manuel Quintana-Díaz, Carlos Jiménez-Vicente, Luis González-Del Valle, Alicia Herrero Ambrosio, Juana Benedí-González
• Impact of pharmacist interventions on drug-related problems in general surgery patients: a randomised controlled trial (13 July, 2020)

  Salah AbuRuz, Deema Jaber, Iman Basheti, Aya Sadeq, Mosab Arafat, Mohammad AlAhmad, Amira Said
• Assessing the quality of drug information provided by hospital pharmacies using a fictitious enquiry and simulated real-life conditions (5 October, 2020)

  Dorothea Strobach, Ute Blassmann, Sigrun Gundl, Sabine Krebs, Christiane Querbach, Carolin Schuhmacher, Claudia Langebrake
• Observational study of drug-related problems and clinical pharmacists’ interventions in a French paediatric hospital (28 October, 2020)

  Sophie Robert, Sophie Ménétré, Cyril Schweitzer, Béatrice Demoré
• Impact of non-formulary drugs on pharmacological prescription in hospitalised patients (8 October, 2020)

  Jaime Barceló-Vidal, Xènia Fernández-Sala, Santiago Grau, Esther Salas, Xavier Duran-Jordan, Marta Riu, Olivia Ferrández
• Assessment of the effectiveness of a pharmacist approach for improving disease-specific knowledge and treatment in patients with chronic obstructive pulmonary disease (13 October, 2020)

  Manjusha Sajith, Medha Deepak Bargaje, Smruti Gharat, Joelin Mathew, Amruta Varghese
• Patient prioritisation for hospital pharmacy services: current approaches in the UK (1 December, 2020)

  Aseel S Abuzour, Gillian Hoad-Reddick, Memona Shahid, Douglas T Steinke, Mary P Tully, Steven David Williams, Penny J Lewis
• Analysis of the third WHO Global Safety Challenge ‘Medication Without Harm’ patient-facing materials: exploratory descriptive study (29 October, 2020)

  Kisshante Subakumar, Bryony Dean Franklin, Sara Garfield
• Economic evaluation of subcutaneous versus intravenous immunoglobulin therapy in chronic inflammatory demyelinating polyneuropathy: a real-life study (29 October, 2020)

  Eugenia Piscitelli, Marida Massa, Bernardo Maria De Martino, Carmela Simona Serio, Gaspare Guglielmi, Giovanni Colacicco, Francesco Tuccillo, Francesco Habetswallner
• Implementation of a novel home delivery service during pandemic (28 October, 2020)

  Ana Peláez Bejarano, Pilar Villar Santos, Maria de las Aguas Robustillo-Cortés, Ernesto Sánchez Gómez, Maria Dolores Santos Rubio
• Implementation of a pharmacy e-interconsultation integrated in patient medical record (16 November, 2020)

  Olatz Ibarra-Barrueta, Eguzkiñe Ibarra-García, Estibaliz Pérez-Díez
• Prospective observational study of medication reviews in internal medicine wards: evaluation of drug-related problems (16 November, 2020)

  Lina Hellström, Tommy Eriksson, Åsa Bondesson
• A new clinical approach to improve the appropriate use of peripherally inserted central catheters: a prospective study (7 January, 2021)

  Marlène Buisson, Géraldine Leguelinel, Sophie Bastide, Jean Paul Beregi, Jean Marie Kinowski, Julien Frandon, Virginie Chasseigne
• Pharmacotherapeutic management of Parkinson’s disease inpatients: how about asking hospital pharmacists? (22 December, 2020)

  Unax Lertxundi Etxebarria, Itziar Palacios-Zabalza, Itziar Ibarrondo, Saioa Domingo-Echaburu, Rafael Hernandez, Arantxa Isla, Marian Solinis
• Impact of transplant pharmacists on length of stay and 30-day hospital readmission rate: a single-centre retrospective cohort study (30 December, 2020)

  Razan Alsheikh, Katie Johnson, Ashlee Dauenhauer, Pradeep Kadambi
• Identification and safe storage of look-alike, sound-alike medicines in automated dispensing cabinets (15 January, 2021) Free

  Henna Karoliina Ruutiainen, Miia Marjukka Kallio, Sini Karoliina Kuitunen
• Impact and acceptance of pharmacist-led interventions during HIV care in a third-level hospital in Spain using the Capacity-Motivation-Opportunity pharmaceutical care model: the IRAFE study (24 February, 2021)

  M Gracia Cantillana-Suárez, Maria de las Aguas Robustillo-Cortés, Antonio Gutiérrez-Pizarraya, Ramón Morillo-Verdugo
• Using risk analysis to anticipate and mitigate failures during a hospital pharmacy relocation (16 March, 2021)

  Laurence Schumacher, Maria Dobrinas, Séverine Krähenbühl, Camilla Pasteur, Marie-Laure Borlat, François Rouiller, Anne-Laure Blanc, Nicolas Widmer, Cédric Blatrie
• Using risk analysis to ensure patients’ medication safety during hospital relocations and evacuations (8 April, 2021)

  Laurence Schumacher, Florian Berthaudin, Anne-Laure Blanc, Cédric Blatrie, Anthony Staines, Pascal Bonnabry, Nicolas Widmer
• Improving shared decision-making in pharmacist-led haematology clinics: a ‘Plan Do Study Act’ approach (26 May, 2021)

  Laura Ferro-López, Nina Barnett, John Minshull
• Financial impact of the hospital pharmacy’s participation in clinical trials (8 June, 2021)

  Irene Lopez-Rico, Roser Vives, Miquel Cruel, Carla Cerdan, Anisi Moron-Besolí, Miguel Angel Ruiz, Victor José de Pedro, Mònica Gómez-Valent
• Impact of pharmacist-led interventions in improving adherence to glaucoma medications in the geriatric population (7 July, 2021)

  Ayesha Aleem, Fatima Amin, Mulazim Hussain Asim, Nayab Farooq, Shumaila Arshad, Mairah Raziq
• Effect of a pharmacist-led educational intervention on clinical outcomes: a randomised controlled study in patients with hypertension, type 2 diabetes and hypercholesterolaemia (28 June, 2021)

  Clement Delage, Hélène Lelong, Francoise Brion, Jacques Blacher